Curriculum · Metabolic and Endocrine and Diabetes Mellitus
Management of hyperglycaemia in the hospitalised patient
The two numbers
Insulin therapy should be initiated in hospitalized patients with persistent hyperglycemia, starting at a threshold of 180 mg/dL. Once insulin therapy is started, a target glucose range of 140 to 180 mg/dL is recommended for the majority of hospitalized patients.
The number to start at and the top of the target range are the same number, 180 mg/dL, and that is what makes 180 mg/dL the maximum blood glucose goal on the ward.
The range is recommended regardless of whether the patients have a critical illness. So the setting does not move it: a 75-year-old admitted to the intensive-care unit with sepsis, with diabetes mellitus and coronary artery disease, is held to the same maximum as the patient on the general ward, not to a lower goal such as 100 mg/dL and not to a higher one such as 220 mg/dL.
The regimen that carries the day-to-day care
The insulin regimen considered the best for the day-to-day management of diabetes is basal-bolus: long-acting basal at night, rapid at meals.
The reason given is that it is similar to physiological insulin, which exists at a baseline level, with insulin spikes that occur after a meal.
Sliding scale in the inpatient setting
In the inpatient setting, sliding scale insulin can be added to an existing basal-bolus regimen. It is added to the regimen and does not take its place.
It works in two steps. First, it allows extra insulin to be given if blood sugar is high. Second, that extra is then added back onto the total daily insulin requirement for the following day, so a high reading today raises the standing dose for the day after it.